Today: 21 May 2026
Industrial stocks ETF XLI slips after tariff whiplash; GE Aerospace and Fed decision set up week ahead
24 January 2026
2 mins read

Industrial stocks ETF XLI slips after tariff whiplash; GE Aerospace and Fed decision set up week ahead

New York, January 24, 2026, 13:10 EST — The market has closed.

U.S. industrial stocks wrapped up the week on a down note, with the Industrial Select Sector SPDR ETF (XLI) slipping 0.77% to close at $164.22 on Friday. As trading resumes Monday, the sector confronts a familiar cocktail of tariffs, interest rates, and earnings reports.

Timing is key. Industrials often act as a gauge for trade policy and the broader economy, both of which have made a comeback on the tape following a rocky start to 2026.

After a week marked by tariff chatter linked to President Donald Trump’s Greenland ambitions, U.S. stocks closed Friday on a mixed note. “We’re feeling pretty good, but mindful we might have some significant twists and turns throughout the rest of the year,” said Jason Blackwell, chief investment strategist at Focus Partners Wealth. Reuters

XLI leans heavily on a handful of companies and sectors, causing more volatility than its “sector ETF” tag might imply. As of Jan. 22, State Street data listed GE Aerospace at around 6% of the index, with Caterpillar, RTX, and Boeing close behind. Aerospace and defense accounted for about 27% of the fund’s industry exposure. State Street Global Advisors

Friday’s tape showed mixed moves among bellwethers. Caterpillar dropped roughly 3.4%, GE Aerospace dipped about 0.4%, and RTX slipped around 0.2%. Boeing, on the other hand, inched up close to 0.3%.

GE Aerospace grabbed attention after its earnings report Thursday. The jet-engine manufacturer projects a 2026 adjusted EPS between $7.10 and $7.40, slightly above analysts’ $7.11 estimate. Airlines are increasingly relying on parts and maintenance — the aftermarket — due to ongoing shortages of new aircraft.

The company described its outlook as an extension of a robust finish to 2025. “We enter 2026 with solid momentum to build upon these results and are well positioned to create greater value for our customers,” CEO Larry Culp said in a statement. GE Aerospace

Culp pushed back against airline claims that engine makers are exploiting shortages to hike prices in an interview with Reuters. “Tariffs and commodity inflation are just part of the equation with respect to thinking about price,” he said, noting that GE invests about $3 billion annually in research and development. Reuters

Macro signals remain murky for industrial traders. S&P Global’s flash composite PMI, an early gauge of business activity, stayed in expansion territory in January. Yet “increased costs, widely blamed on tariffs, are again cited as a key driver of higher prices,” noted Chris Williamson, chief business economist at S&P Global Market Intelligence. Reuters

The next hurdle is just around the corner: the Federal Reserve’s moves and a packed schedule of corporate earnings. “It’s been a little bit of a short but steep roller-coaster ride,” said Yung-Yu Ma, chief investment strategist at PNC Financial Services Group, as markets try to steady themselves following the Greenland trade jitters. Reuters

The Fed’s two-day meeting is scheduled for Jan. 27–28, with its policy decision expected at 2:00 p.m. ET on Jan. 28. A press conference will follow at 2:30 p.m., according to the central bank’s calendar.

The sector’s downside is clear. Should tariff talk ramp up again, industrials will get hit twice—higher input costs plus slumping export demand. And if the Fed turns hawkish on inflation, expect the most sensitive stocks to adjust sharply, fast.

Investors are also eyeing a batch of U.S. data known to sway industrial sector forecasts — starting with durable goods orders on Monday, followed by consumer confidence on Tuesday, and jobless claims on Thursday. These reports often tip the scales on the debate between a “soft landing vs. slowdown” for industrial stocks. kiplinger.com

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Dow Jones slides 285 points on Intel shock — here’s what Wall Street watches next week
Previous Story

Dow Jones slides 285 points on Intel shock — here’s what Wall Street watches next week

IBM stock price dips into the weekend as investors brace for Jan. 28 earnings
Next Story

IBM stock price dips into the weekend as investors brace for Jan. 28 earnings

Go toTop